Table 1 Demographic and treatment variables during chemoradiation
| Â | Taking protease inhibitors n (%) | Not taking protease inhibitors n (%) | p-value |
|---|---|---|---|
153 (69.86) | 66 (30.14) | Â | |
Age at diagnosis | Â | Â | 0.19 |
  < 40 | 10 (6.54) | 2 (3.03) |  |
 40–59 | 104 (67.97) | 40 (60.61) |  |
 60+ | 39 (25.49) | 24 (36.36) |  |
Race/Ethnicity | Â | Â | 0.78 |
 African American | 55 (35.95) | 21 (31.82) |  |
 Caucasian | 78 (50.98) | 33 (50.00) |  |
 Hispanic | 11 (7.19) | 7 (10.61) |  |
 Other/Unknown | 9 (5.88) | 5 (7.58) |  |
Year HIV Diagnosed | Â | Â | 0.37 |
  < 2000 | 103 (67.32) | 39 (59.09) |  |
 2000–2009 | 39 (25.49) | 23 (34.85) |  |
 2010–2016 | 11 (7.19) | 4 (6.06) |  |
Smoker | Â | Â | 0.80 |
 Current | 76 (49.67) | 37 (56.06) |  |
 Former | 28 (18.30) | 10 (15.15) |  |
 Never | 41 (26.80) | 15 (22.73) |  |
 Unknown | 8 (5.23) | 4 (6.06) |  |
Stage | Â | Â | 0.28 |
 I | 21 (13.73) | 15 (22.73) |  |
 II | 73 (47.71) | 34 (51.52) |  |
 IIIA | 15 (9.80) | 3 (4.55) |  |
 IIIB | 35 (22.88) | 13 (19.70) |  |
 IV | 6 (3.92) | 1 (1.52) |  |
 Unknown | 3 (1.96) | 0 (0) |  |
CD4 at HIV Diagnosis |  |  | < 0.01 |
  ≤ 200 | 55 (35.95) | 20 (30.30) |  |
  > 200 | 59 (38.56) | 42 (63.64) |  |
 Unknown | 39 (25.49) | 4 (6.06) |  |
CD4 at Cancer Diagnosis |  |  | < 0.01 |
  ≤ 200 | 43 (28.10) | 8 (12.12) |  |
  > 200 | 101 (66.01) | 58 (87.88) |  |
 Unknown | 9 (5.88) | 0 (0) |  |
Nadir CD4 during Radiation |  |  | < 0.01 |
  ≤ 200 | 79 (51.63) | 20 (30.30) |  |
  > 200 | 33 (21.57) | 25 (37.88) |  |
 missing | 41 (26.80) | 21 (31.82) |  |
BMI | Â | Â | 0.05 |
  < 25 | 76 (49.67) | 37 (56.06) |  |
 25–29.9 | 53 (34.64) | 18 (27.27) |  |
 ≥ 30 | 14 (9.15) | 11 (16.67) |  |
 Unknown | 10 (6.54) | 0 (0) |  |
Alcohol Use | Â | Â | 0.73 |
 Yes | 57 (37.25) | 23 (34.85) |  |
 No | 96 (62.75) | 43 (65.15) |  |
History of prior cancer | Â | Â | 0.14 |
 Yes | 22 (14.38) | 14 (21.21) |  |
 No | 129 (84.31) | 49 (74.24) |  |
 Unknown | 2 (1.31) | 3 (4.55) |  |
Radiation Modality | Â | Â | 0.87 |
 2D + 3D | 54 (35.29) | 21 (31.82) |  |
 IMRT | 52 (33.99) | 23 (34.85) |  |
 Unknown | 47 (30.72) | 22 (33.33) |  |
Completed Radiation Treatment | Â | Â | 0.48 |
 Yes | 134 (87.58) | 60 (90.91) |  |
 No | 19 (12.42) | 6 (9.09) |  |
Length of Radiation Treatment | Â | Â | 0.59 |
  ≤ 50 days | 86 (56.21) | 42 (63.64) |  |
  > 50 days | 61 (39.87) | 22 (33.33) |  |
 Unknown | 6 (3.92) | 2 (3.03) |  |
Chemotherapy Regimen | Â | Â | 0.05 |
 5FU + mitomycin C | 115 (75.16) | 47 (71.21) |  |
 5FU + cisplatin | 20 (13.07) | 4 (6.06) |  |
 other | 18 (11.76) | 15 (22.73) |  |
Chemotherapy Dose Reduction | Â | Â | 0.25 |
 Yes | 49 (32.03) | 16 (24.24) |  |
 No | 104 (67.97) | 50 (75.76) |  |